Tech Company Inital Public Offerings

Adagio Therapeutics IPO

Headquartered in Waltham, Adagio Therapeutics is now a public company.

Transaction Overview

Announced On
8/6/2021
Transaction Type
IPO
Amount
$309,400,000
Proceeds Purpose
The company will use the IPO proceeds to fund clinical development, manufacturing supply and initial commercialization costs for ADG20. Proceeds will also be used for working capital and other general corporate purposes, including development of additional programs in our pipeline.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
303 Wyman St. 300
Waltham, MA 02451
USA
Phone
Undisclosed
Email Address
Overview
Adagio is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional potentially emergent coronaviruses. We believe our antibodies will match or exceed the potency and coverage of conventional SARS-CoV-2 antibody programs, and can be used as both therapeutic and durable prophylactic treatments.
Profile
Adagio Therapeutics LinkedIn Company Profile
Social Media
Adagio Therapeutics Company Twitter Account
Company News
Adagio Therapeutics News
Facebook
Adagio Therapeutics on Facebook
YouTube
Adagio Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Tillman Gerngross
  Tillman Gerngross LinkedIn Profile  Tillman Gerngross Twitter Account  Tillman Gerngross News  Tillman Gerngross on Facebook
Chief Financial Officer
Jane Henderson
  Jane Henderson LinkedIn Profile  Jane Henderson Twitter Account  Jane Henderson News  Jane Henderson on Facebook
Chief Medical Officer
Lynn Connolly
  Lynn Connolly LinkedIn Profile  Lynn Connolly Twitter Account  Lynn Connolly News  Lynn Connolly on Facebook
Chief Operating Officer
Halley Gilbert
  Halley Gilbert LinkedIn Profile  Halley Gilbert Twitter Account  Halley Gilbert News  Halley Gilbert on Facebook
Chief Scientific Officer
Laura Walker
  Laura Walker LinkedIn Profile  Laura Walker Twitter Account  Laura Walker News  Laura Walker on Facebook
Chief Technical Officer
Becky Dabora
  Becky Dabora LinkedIn Profile  Becky Dabora Twitter Account  Becky Dabora News  Becky Dabora on Facebook
VP - Bus. Development
Ellie Hershberger
  Ellie Hershberger LinkedIn Profile  Ellie Hershberger Twitter Account  Ellie Hershberger News  Ellie Hershberger on Facebook
VP - Bus. Development
Eric Kimble
  Eric Kimble LinkedIn Profile  Eric Kimble Twitter Account  Eric Kimble News  Eric Kimble on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/6/2021: Bluecore venture capital transaction
Next: 8/6/2021: Octane Lending venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary